Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Fiore Bavaro

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Therapeutic Drug Monitoring|May 22, 2025
Potential Role of Therapeutic Drug Monitoring in Preventing Antibiotic-Induced Neuropsychiatric Disorders: A Narrative ReviewDario Cattaneo, Davide Fiore Bavaro, Michele Bartoletti
Viruses|May 27, 2023
HIV and Co-Infections: Updates and InsightsFrancesco Di Gennaro, Alessandra Vergori, Davide Fiore Bavaro
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2023
What do clinicians mean by epidemics' preparednessMichele Bartoletti, Linda Bussini, Davide Fiore Bavaro, et al.
Expert Opinion on Drug Safety|May 13, 2020
Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infectionsDavide Fiore Bavaro, Deborah Fiordelisi, Gioacchino Angarano, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-AnalysisAlberto Enrico Maraolo, Agnese Giaccone, Ivan Gentile, et al.
Infectious Disease Reports|August 27, 2025
<i>Clostridioides difficile</i> Infection in the United States of America-A Comparative Event Risk Analysis of Patients Treated with Fidaxomicin vs. Vancomycin Across 67 Large Healthcare ProvidersSebastian M Wingen-Heimann, Christoph Lübbert, Davide Fiore Bavaro, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
<i>Stenotrophomonas maltophilia</i> Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic OptionsAlberto Enrico Maraolo, Federica Licciardi, Ivan Gentile, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i>: A Retrospective Case Series and Literature ReviewAlessandra Belati, Davide Fiore Bavaro, Lucia Diella, et al.
Journal of Medical Virology|December 23, 2018
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individualsDavide Fiore Bavaro, Annalisa Saracino, Deborah Fiordelisi, et al.
American Journal of Infection Control|March 10, 2020
Sphingomonas paucimobilis outbreak in a dialysis room: Case report and literature review of an emerging healthcare associated infectionDavide Fiore Bavaro, Michele Fabiano Mariani, Emma Diletta Stea, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Therapeutic Drug Monitoring|May 22, 2025
Potential Role of Therapeutic Drug Monitoring in Preventing Antibiotic-Induced Neuropsychiatric Disorders: A Narrative ReviewDario Cattaneo, Davide Fiore Bavaro, Michele Bartoletti
Viruses|May 27, 2023
HIV and Co-Infections: Updates and InsightsFrancesco Di Gennaro, Alessandra Vergori, Davide Fiore Bavaro
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2023
What do clinicians mean by epidemics' preparednessMichele Bartoletti, Linda Bussini, Davide Fiore Bavaro, et al.
Expert Opinion on Drug Safety|May 13, 2020
Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infectionsDavide Fiore Bavaro, Deborah Fiordelisi, Gioacchino Angarano, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-AnalysisAlberto Enrico Maraolo, Agnese Giaccone, Ivan Gentile, et al.
Infectious Disease Reports|August 27, 2025
<i>Clostridioides difficile</i> Infection in the United States of America-A Comparative Event Risk Analysis of Patients Treated with Fidaxomicin vs. Vancomycin Across 67 Large Healthcare ProvidersSebastian M Wingen-Heimann, Christoph Lübbert, Davide Fiore Bavaro, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
<i>Stenotrophomonas maltophilia</i> Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic OptionsAlberto Enrico Maraolo, Federica Licciardi, Ivan Gentile, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i>: A Retrospective Case Series and Literature ReviewAlessandra Belati, Davide Fiore Bavaro, Lucia Diella, et al.
Journal of Medical Virology|December 23, 2018
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individualsDavide Fiore Bavaro, Annalisa Saracino, Deborah Fiordelisi, et al.
American Journal of Infection Control|March 10, 2020
Sphingomonas paucimobilis outbreak in a dialysis room: Case report and literature review of an emerging healthcare associated infectionDavide Fiore Bavaro, Michele Fabiano Mariani, Emma Diletta Stea, et al.
Pageof 9